top
Search terms
Results 1 - 10 of 58 - ordered by :
Pages: 1 2 3 4 5 6 ... 6
Heart

Randomised controlled trials performed in high risk patients, such as patients with ischaemic heart disease and left ventricular dysfunction, showed that an approach based on antiarrhythmic drugs is ...

Heart, Editorial, Giuseppe Boriani, Igor Diemberger

Date : 01/06/2012
Heart

Houman Ashrafian, Hugh Watkins Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK Drs Houman Ashrafian, and Hugh Watkins, Department of ...

Heart, Editorial, Houman Ashrafian, Hugh Watkins

Date : 01/10/2008
Eurointervention

Cardiology Department, Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada The introduction of the so-called newer-generation transcatheter aortic valve implantation (TAVI) ...

Date : 17/09/2015 Item size : 33325 bytes
Epeuropace

Methods and results The study population consisted of patients with an ejection fraction 40% undergoing ICD implantation (n = 911) for the primary or secondary prevention of sudden cardiac death from ...

Europace, CLINICAL RESEARCH, Sanjeev P. Bhavnani, Anupam Kumar, Craig I. Coleman, Danette Guertin, Ravi K. Yarlagadda, Christopher A. Clyne, Jeffrey Kluger

Date : 01/01/2014 Item size : 271887 bytes
Epeuropace

Abstract Aims To evaluate the incidences of and risk factors predisposing to appropriate and inappropriate shocks and mortality in a real-world population of patients with ischaemic heart disease ...

Europace, CLINICAL RESEARCH, Peter Weeke, Jens Brock Johansen, Ole Dan Jørgensen, Jens Cosedis Nielsen, Mogens Møller, Regitze Videbæk, Michael Vinther Højgaard, Sam Riahi, Peter Karl ...

Date : 01/08/2013 Item size : 269036 bytes
Epeuropace

Introduction The past decade has seen rapid progress in cardiac implantable electronic devices delivering implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy ...

Europace, Editorial, Francisco Leyva, Christopher J. Plummer

Date : 01/03/2015 Item size : 144334 bytes
Epeuropace

CAA may involve an abnormal origin (number, location, size, angle of origination), course (intramural aortic), termination, or structure (fistula) of the coronary arteries.1 Most CAAs are clinically ...

Europace, Short Communication, Petr Parizek, Ludek Haman, Jan Harrer, Miloslav Tauchman, Vladimir Rozsival, Ivo Varvarovsky, Miloslav Pleskot, Miroslav Mestan, Josef Stasek

Date : 01/09/2010 Item size : 143721 bytes
AnatolianJournal

Selective implantation of cardioverter-defibrillators in patients with genetic heart disease and sudden death risk [Anatol J Cardiol] The implantable cardioverter-defibrillator (ICD) therapy is an ...

Date : 12/01/2017 Item size : 32771 bytes
AnatolianJournal

Microvolt T-wave alternans profiles in patients with pulmonary arterial hypertension compared to patients with left ventricular systolic dysfunction and a group of healthy volunteers [Anatol J ...

Date : 13/01/2017 Item size : 38065 bytes
Epeuropace

Abstract Aims The purpose of this study is to investigate compliance to established guidelines regarding primary prevention with implantable cardioverter-defibrillator (ICD) in patients with left ...

Europace, Sudden Death and ICDs, Johanna Sjöblom, Lina Ljung, Mats Frick, Mårten Rosenqvist, Viveka Frykman

Date : 01/04/2012